Main Industry
Biotechnology
Main Product/Service
1. Technology Platform
2. 505(b)(2) NDA
3. High Barrier ANDA
2. 505(b)(2) NDA
3. High Barrier ANDA
Founded Year
2014
Unified Business No.
24546157
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,699,819,000 (NT$)
Location of Company
Taiwan
, Tainan City
Exit Status
Emerging Stock Exchange(2016)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche portfolios. The company’s business strategy comprises utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China).
We specialize in controlled-release technology and products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its 505(b)(2) New Drug Applications (NDA) and High barrier-Abbreviated New Drug Applications (ANDA) to the United States Food and Drug Administration (FDA).
We specialize in controlled-release technology and products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its 505(b)(2) New Drug Applications (NDA) and High barrier-Abbreviated New Drug Applications (ANDA) to the United States Food and Drug Administration (FDA).
